A graduate of Hacettepe University, Faculty of Medicine (M.D. 1990, Ankara) and University of Toronto (clinical pharmacology, M.Sc., 1994; Ph.D., 1998), Vural Özdemir completed a 4-year OMHF-funded postdoctoral fellowship in pharmacogenetics and personalized medicine with Werner Kalow, a pioneer and founder of the field of pharmacogenetics. He was accredited by the American Board of Clinical Pharmacology in 2003 (DABCP).
Vural has authored more than 120 peer-reviewed articles and book chapters in clinical pharmacology on the translation continuum from discovery science to global health, and the socio-technical and political systems that co-produce scientific knowledge in 21st century data-intensive OMICS life sciences.
This academic research aims to advance open user innovation in the field of "Big Data", and the new concept of "second-order reflexivity" for sustainable innovation in pharmacogenetics and personalized medicine (Dove & Özdemir 2013 Personalized Medicine 10(3), in press).
Vural's professional community affiliations include the Society for Social Studies of Science (4S) and the American Society for Clinical Pharmacology & Therapeutics (ASCPT).